JK Agri Genetics
Close ·
- P/E
- Not meaningful: loss-making over the last twelve months
Key Fundamentals
MicrocapConsumer GoodsFMCGPrice-based figures at the close · EPS basis: Consolidated · TTM
- ROCE
- 5.25%
- Debt to Equity
- 0.00
- EPS (TTM)
- −₹15.47
- Book Value
- ₹216.43
- Market Cap
- —
- P/E (TTM)
- Not meaningful: loss-making over the last twelve months
- P/B
- 1.11
- ROE
- −8.06%
- Dividend Yield
- 0.62%
- EBITDA
- ₹9.50 Cr
- 52W High
- ₹479.90
- 52W Low
- ₹234.00
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 93/100
Category scores
- Quality
- 30
- Poor
- Returns, margins, earnings quality 22% weight
- Valuation
- 38
- Weak
- Cheap vs sector & own history 24% weight
- Growth
- 33
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 41
- Weak
- Solvency, leverage, coverage 9% weight
- Momentum
- 16
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
2- Company has reduced debt.
- Company is almost debt free.
Weaknesses
3- Company has low interest coverage ratio.
- Earnings include an other income of Rs.6.18 Cr.
- Company's cost of borrowing seems high
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 12 | 3 | 4 |
| Oscillators | Bullish | 2 | 3 | 4 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Bullish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 33.77
- Neutral
- MACD (12,26,9)
- −11.04
- Bearish
- SMA (50)
- 281.16
- Bearish
- SMA (200)
- 317.13
- Bearish
As of
Growth Rate
From the financial statements below. 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 1Y | −2.47% |
|---|
Net profit
| 1Y | Loss widened by ₹4 Cr |
|---|
Operating cash flow
| 1Y | Turned negative |
|---|
Operating margin· change in pp
| 1Y | +7.44 pp |
|---|
Trailing twelve months: Fewer than eight quarters are reported, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2025 | ₹162 Cr |
|---|---|
| Mar 2026 | ₹158 Cr |
Net profit by year
| Mar 2025 | −₹3.00 Cr |
|---|---|
| Mar 2026 | −₹7.00 Cr |
Quarterly Results
₹ CrResults for the period ended Jun 2026 were due by 14 Aug 2026 and are not in this table yet.
| Particulars | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 27.59 | 91.93 | 19.07 | 23.63 | 22.96 |
| Expenses | 28.42 | 74.12 | 25.61 | 32.07 | 24.15 |
| Operating Profit | −0.83 | 17.81 | −6.54 | −8.44 | −1.19 |
| OPM % | −3.01% | 19.37% | −34.29% | −35.72% | −5.18% |
| Other Income | 2.06 | 2.25 | 1.14 | 2.94 | 0.69 |
| Interest | 1.02 | 1.16 | 1.35 | 1.09 | 0.93 |
| Depreciation | 0.97 | 1.18 | 0.85 | 0.68 | 1.16 |
| PBT | −0.76 | 17.72 | −7.6 | −7.27 | −2.59 |
| Tax % | 77.63% | 30.7% | −32.89% | −27.51% | 250.97% |
| Net Profit | −1.35 | 12.28 | −5.09 | −5.27 | −9.09 |
| EPS (₹) | −2.91 | 26.48 | −10.98 | −11.37 | −19.6 |
Profit & Loss
₹ Cr| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Sales | 162 | 158 |
| Expenses | 172 | 155 |
| Operating Profit | −10 | 2 |
| OPM % | −6% | 1.6% |
| Other Income | 18 | 6 |
| Interest | 6 | 5 |
| Depreciation | 4 | 4 |
| PBT | −2 | 0 |
| Tax % | 2% | 2858% |
| Net Profit | −3 | −7 |
| EPS (₹) | −5.41 | −15.46 |
| Div. Payout % | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Equity Capital | 5 | 5 |
| Reserves | 103 | 96 |
| Borrowings | 3 | 0 |
| Other Liabilities | 187 | 172 |
| Total Liabilities | 297 | 272 |
| Fixed Assets | 19 | 22 |
| CWIP | 18 | 7 |
| Investments | 98 | 73 |
| Other Assets | 162 | 170 |
| Total Assets | 297 | 272 |
Cash Flow
₹ Cr| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Operating | 3 | −28 |
| Investing | 32 | 30 |
| Financing | −34 | −7 |
| Net Cash Flow | 1 | −5 |
| Free Cash Flow | 72 | −29 |
| CFO/OP | −42 | −1,122 |
Ratios
| Particulars | Mar 2025 | Mar 2026 |
|---|---|---|
| Debtor Days | 96 | 88 |
| Inventory Days | 301 | 469 |
| Days Payable | 387 | 396 |
| Cash Conversion Cycle | 9 | 161 |
| Working Capital Days | −139 | −53 |
| ROCE % | — | 5% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view JK Agri Genetics insights
70 extracted metrics across FY11–FY27.
Documents
- 2 Sep 2026
- 25 Feb 2026
- 9 Jan 2025
- 29 Nov 2023
- 6 Oct 2022
- General announcements 30 Oct 2026
- General announcements 30 Oct 2026
Frequently Asked Questions about JK Agri Genetics
What does JK Agri Genetics Ltd do?
Where is JK Agri Genetics Ltd (JKAGRI) listed?
Which sector does JK Agri Genetics Ltd belong to?
What is the 52-week high and low of JK Agri Genetics Ltd?
Does JK Agri Genetics Ltd pay dividends?
What is the Return on Equity (ROE) of JK Agri Genetics Ltd?
Company Information
JK Agri Genetics Ltd (JKAGL), part of the JK Group and a 67.56% subsidiary of Bengal & Assam Company Ltd, research, develops, produces, processes and markets hybrid /certified seeds under the JK Seeds brand. Its portfolio covers cotton, maize, paddy, pearl millet/bajra, jowar/sorghum, mustard, wheat, sorghum-Sudan grass and vegetables such as tomato, okra and chilli.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/536493.md for JK Agri Genetics Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.